Diego Cadavid

Dr. Diego Cadavid is an Instructor in the Department of Neurology at UMass Chan Medical School (T.H. Chan School of Medicine). His research and clinical work focus on neurological disorders, with particular expertise in multiple sclerosis, neuromuscular diseases, and neuroinfectious conditions.

Education:

• MD from Pontifical Xavierian University, Bogota, Colombia

Dr. Cadavid's research spans multiple areas of neurology, with a strong emphasis on clinical trials and translational research. His work in multiple sclerosis has focused on novel therapeutic approaches, imaging biomarkers, and clinical outcome measures. He has also made significant contributions to research on facioscapulohumeral muscular dystrophy (FSHD), fragile X syndrome, and Lyme disease neuroborreliosis. His expertise in clinical trial design and execution is evident from his involvement in numerous phase 1-3 trials of novel therapeutics.

Analysis of Dr. Cadavid's recent publications reveals a strong focus on neuromuscular disorders, particularly FSHD, where he has been involved in multiple clinical trials of losmapimod. He also maintains active research programs in multiple sclerosis therapeutics (including opicinumab trials) and fragile X syndrome biomarkers. His work often bridges basic science and clinical applications, with an emphasis on developing reliable biomarkers and outcome measures for neurological conditions.

Dr. Cadavid has served as an investigator in numerous clinical trials, including the ReDUX4 trial of losmapimod for FSHD, the SYNERGY trial of opicinumab for multiple sclerosis, and various studies of fragile X syndrome. His research has been supported by both industry and institutional funding sources, reflecting the translational nature of his work.